Company Overview of SR One
SR One is the venture capital arm of GlaxoSmithKline specializing in investing in seed, start up, early and mid venture; and emerging growth companies. It seeks to invest in emerging life science companies that are pursuing innovative science which will significantly impact medical care, with products in preclinical development stage through clinical proof-of-concept; biotechnology; healthcare; medical devices, and related information technologies companies. It typically invests in companies based globally with a focus on the United States, Canada, and Europe. The firm typically invests between $500,000 and $5 million per round. It prefers to take a board seat or observers right in its portf...
161 Washington Street
Eight Tower Bridge
Conshohocken, PA 19428-2077
Founded in 1985
Key Executives for SR One
Compensation as of Fiscal Year 2014.
SR One Key Developments
SR One Presents at 3rd Annual SACHS Cancer Bio Partnering and Investment Forum, Feb-23-2015 05:00 PM
Feb 22 15
SR One Presents at 3rd Annual SACHS Cancer Bio Partnering and Investment Forum, Feb-23-2015 05:00 PM. Venue: The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St, 40th Floor (D Elevator Bank), New York, NY10007, United States. Speakers: Jens W. Eckstein, President.
SR One Presents at 8th Annual EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITION, Mar-03-2015 11:15 AM
Feb 18 15
SR One Presents at 8th Annual EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITION, Mar-03-2015 11:15 AM. Venue: Hilton, Zurich Airport Hotel, Hohenbuehlstrasse 10, Opfikon-Glattbrugg 8152 Zurich, Zurich, Switzerland. Speakers: David Phillips, Partner.
SR One Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014 09:00 AM
Sep 10 14
SR One Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014 09:00 AM. Venue: Boston Marriott Copley Place, 110 Huntington Avenue, Boston, MA 02116, United States. Speakers: Brian M. Gallagher, Partner.
Similar Private Companies By Industry
Recent Private Companies Transactions